Go Pro

C4 Therapeutics (CCCC) Institutional Ownership

C4 Therapeutics logo
$4.24 +0.16 (+3.92%)
Closing price 04:00 PM Eastern
Extended Trading
$4.26 +0.02 (+0.47%)
As of 05:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for C4 Therapeutics (NASDAQ:CCCC)

Current
Institutional Ownership
Percentage
78.81%
Number of
Institutional Buyers
(last 12 months)
52
Total
Institutional Inflows
(last 12 months)
$48.67M
Number of
Institutional Sellers
(last 12 months)
14
Total
Institutional Outflows
(last 12 months)
$27.19M
Get CCCC Insider Trade Alerts

Want to know when executives and insiders are buying or selling C4 Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CCCC Institutional Buying and Selling by Quarter

C4 Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/6/2026 Bank of New York Mellon Corp249,517$1.17M0.0%N/A0.226%
7/10/2026 Wasatch Advisors LP3,522,644$16.45M0.1%+18.9%3.186%
6/4/2026Seven Fleet Capital Management LP57,076$150K0.0%N/A0.052%
5/21/2026CTC Alternative Strategies Ltd.10,792$28K0.1%N/A0.010%
5/19/2026Bank of America Corp DE2,359,241$6.21M0.0%-1.2%2.134%
5/19/2026Stempoint Capital LP453,236$1.19M0.2%N/A0.410%
5/18/2026ADAR1 Capital Management LLC43,000$113K0.0%N/A0.039%
5/18/2026Readystate Asset Management LP49,586$130K0.0%N/A0.045%
5/16/2026SummitTX Capital L.P.10,466$28K0.0%N/A0.009%
5/16/2026Orbimed Advisors LLC856,353$2.25M0.0%-39.0%0.774%
5/15/2026OMERS ADMINISTRATION Corp59,700$157K0.0%-49.3%0.054%
5/14/2026Renaissance Technologies LLC2,461,815$6.48M0.0%+53.6%2.234%
5/14/2026Sei Investments Co.25,134$66K0.0%N/A0.023%
5/7/2026 Dimensional Fund Advisors LP442,518$1.16M0.0%+49.3%0.402%
4/21/2026 Wasatch Advisors LP2,961,761$7.79M0.1%-31.8%3.035%
2/23/2026Virtu Financial LLC20,655$39K0.0%N/A0.021%
2/19/2026Invesco Ltd.268,350$513K0.0%+39.9%0.277%
2/18/2026XTX Topco Ltd104,458$200K0.0%-30.3%0.108%
2/18/2026 Quadrature Capital Ltd133,112$254K0.0%N/A0.137%
2/18/2026Orbimed Advisors LLC1,404,902$2.68M0.1%-73.2%1.450%
2/18/2026Millennium Management LLC1,188,969$2.27M0.0%-41.3%1.227%
2/18/2026Man Group plc156,098$298K0.0%+72.9%0.161%
2/18/2026Intrepid Family Office LLC55,000$105K0.1%-21.4%0.057%
2/18/2026Engineers Gate Manager LP24,416$47K0.0%+49.9%0.025%
2/18/2026Bridgeway Capital Management LLC131,100$250K0.0%+64.1%0.135%
2/18/2026683 Capital Management LLC400,000$764K0.0%N/A0.413%
2/17/2026RA Capital Management L.P.8,000,000$15.28M0.2%N/A8.255%
2/17/2026Bain Capital Life Sciences Investors LLC7,171,910$13.70M1.0%+545.0%7.401%
2/17/2026Atom Investors LP104,964$200K0.0%N/A0.108%
2/17/2026ExodusPoint Capital Management LP62,165$119K0.0%N/A0.064%
2/17/2026Graham Capital Management L.P.102,198$195K0.0%+151.5%0.105%
2/16/2026Squarepoint Ops LLC136,054$260K0.0%+1,247.2%0.140%
2/16/2026OMERS ADMINISTRATION Corp117,700$225K0.0%N/A0.121%
2/16/2026Barclays PLC219,204$419K0.0%+409.0%0.226%
2/13/2026Marshall Wace LLP265,027$506K0.0%+149.4%0.273%
2/13/2026Hudson Bay Capital Management LP111,551$213K0.0%N/A0.115%
2/13/2026Charles Schwab Investment Management Inc.449,432$858K0.0%+28.2%0.464%
2/13/2026 State Street Corp342,773$655K0.0%+19.3%0.354%
2/13/2026Wells Fargo & Company MN809,260$1.55M0.0%+4,236.9%0.835%
2/12/2026 Wasatch Advisors LP4,344,918$8.30M0.0%-10.5%4.483%
One wafer-scale chip does in minutes what AI takes days (Ad)

NVIDIA has dominated the AI computing race, but history shows even titans can be dethroned, just ask IBM. Three companies are converging in what one publisher calls the Trillion Dollar Triangle, a partnership that could make today's data centers obsolete. A new video breaks down the full story, including the names behind this potential shift in computing power.tc pixel

Watch the video to see the three companies now
2/12/2026Jane Street Group LLC874,794$1.67M0.0%+329.7%0.903%
2/12/2026Renaissance Technologies LLC1,602,580$3.06M0.0%+71.0%1.654%
2/12/2026 Dimensional Fund Advisors LP296,480$566K0.0%-15.1%0.306%
2/11/2026 LPL Financial LLC243,305$465K0.0%+21.1%0.251%
2/10/2026Goldman Sachs Group Inc.1,089,020$2.08M0.0%+136.8%1.124%
2/9/2026 Geode Capital Management LLC988,878$1.89M0.0%+36.3%1.020%
1/30/2026Delta Investment Management LLC20,000$38K0.0%N/A0.021%
1/14/2026 Hennion & Walsh Asset Management Inc.237,137$453K0.0%+15.7%0.245%
11/19/2025 Caitong International Asset Management Co. Ltd19,146$43K0.0%N/A0.020%
11/17/2025Jacobs Levy Equity Management Inc.503,145$1.12M0.0%+13.9%0.519%
11/17/2025Voleon Capital Management LP28,420$63K0.0%N/A0.029%
11/17/2025 Wasatch Advisors LP4,852,741$10.77M0.1%-34.6%5.007%
11/17/2025Qube Research & Technologies Ltd115,973$257K0.0%N/A0.120%
11/17/2025Mariner LLC128,237$285K0.0%-3.4%0.132%
11/17/2025Bank of America Corp DE2,053,162$4.56M0.0%+2.2%2.119%
11/17/2025Algert Global LLC106,300$236K0.0%N/A0.110%
11/14/2025Zacks Investment Management13,043$29K0.0%N/A0.018%
11/14/2025Man Group plc90,278$200K0.0%+15.0%0.127%
11/14/2025Orbimed Advisors LLC5,235,146$11.62M0.3%-23.4%7.356%
11/14/2025Shay Capital LLC420,000$932K0.1%N/A0.590%
11/14/2025Two Sigma Investments LP834,726$1.85M0.0%+22.1%1.173%
11/14/2025Bridgeway Capital Management LLC79,900$177K0.0%-23.8%0.112%
11/13/2025BNP Paribas Financial Markets80,806$179K0.0%-60.8%0.114%
11/13/2025Jefferies Financial Group Inc.38,200$85K0.0%N/A0.054%
11/12/2025 Dimensional Fund Advisors LP349,289$775K0.0%-19.1%0.491%
11/12/2025 R Squared Ltd17,880$40K0.0%-41.5%0.025%
11/7/2025 Crestwood Advisors Group LLC66,536$148K0.0%+129.4%0.093%
11/7/2025Vanguard Group Inc.3,191,557$7.09M0.0%+5.7%4.484%
11/4/2025 State of Wyoming82,509$183K0.0%N/A0.116%
8/15/2025 Tower Research Capital LLC TRC 40,592$58K0.0%+458.0%0.057%
8/15/2025 Wasatch Advisors LP7,424,662$10.62M0.1%+10.4%10.432%
8/15/2025Man Group plc78,487$112K0.0%-8.3%0.110%
8/15/2025BNP Paribas Financial Markets206,177$295K0.0%+1,039.4%0.290%
8/15/2025Bridgeway Capital Management LLC104,900$150K0.0%-19.2%0.147%
8/15/2025Bank of America Corp DE2,008,004$2.87M0.0%+0.9%2.821%
8/15/2025Adage Capital Partners GP L.L.C.200,000$286K0.0%-87.1%0.281%
8/14/2025Jane Street Group LLC492,612$704K0.0%+3,816.8%0.692%
8/13/2025Invesco Ltd.155,017$222K0.0%+11.1%0.218%
8/12/2025XTX Topco Ltd108,278$155K0.0%+170.0%0.152%
8/12/2025Dynamic Technology Lab Private Ltd21,476$31K0.0%N/A0.030%
8/12/2025 Catalyst Funds Management Pty Ltd28,300$40K0.0%N/A0.040%
8/8/2025 Geode Capital Management LLC745,053$1.07M0.0%-47.9%1.049%
8/6/2025 Savant Capital LLC26,347$38K0.0%N/A0.037%
8/5/2025 Crestwood Advisors Group LLC29,000$41K0.0%N/A0.041%
8/1/2025 Y Intercept Hong Kong Ltd52,521$75K0.0%N/A0.074%
7/31/2025 R Squared Ltd30,587$44K0.0%N/A0.043%
7/30/2025 Brookstone Capital Management29,325$42K0.0%N/A0.041%
6/27/2025Goldman Sachs Group Inc.622,720$996K0.0%+8.6%0.877%
5/29/2025Rhumbline Advisers89,633$143K0.0%-10.4%0.126%
5/21/2025Acadian Asset Management LLC27,675$43K0.0%N/A0.039%
Your book attached (Ad)

Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel

Download the Safe Trade Options Formula book for free before access closes
5/16/2025Goldman Sachs Group Inc.622,720$996K0.0%+8.6%0.877%
5/16/2025Jacobs Levy Equity Management Inc.697,653$1.12M0.0%N/A0.983%
5/16/2025AQR Capital Management LLC140,532$225K0.0%+957.6%0.198%
5/14/2025MetLife Investment Management LLC15,893$25K0.0%-44.9%0.022%
5/13/2025American Century Companies Inc.141,986$227K0.0%+6.9%0.200%
5/12/2025Nuveen LLC192,424$308K0.0%N/A0.271%
5/12/2025Invesco Ltd.139,486$223K0.0%+101.6%0.196%
5/9/2025Deutsche Bank AG46,225$74K0.0%N/A0.065%
5/9/2025Charles Schwab Investment Management Inc.474,843$760K0.0%-2.4%0.669%
5/8/2025XTX Topco Ltd40,100$64K0.0%N/A0.056%


CCCC Institutional Ownership - Frequently Asked Questions

During the previous two years, 113 institutional investors and hedge funds held shares of C4 Therapeutics. The most heavily invested institutionals were Soleus Capital Management L.P. ($25.12M), Lynx1 Capital Management LP ($24.67M), Wasatch Advisors LP ($16.45M), RA Capital Management L.P. ($15.28M), Bain Capital Life Sciences Investors LLC ($13.70M), Vanguard Group Inc. ($7.09M), and Point72 Asset Management L.P. ($6.85M).Learn more on C4 Therapeutics' institutional investors.

78.81% of C4 Therapeutics' stock is owned by institutional investors. Learn more on CCCC's institutional investor holdings.

Of the 99 institutional investors that purchased C4 Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($8M), Bain Capital Life Sciences Investors LLC ($6.06M), Lynx1 Capital Management LP ($3.25M), Wasatch Advisors LP ($2.49M), Renaissance Technologies LLC ($1.52M), Jane Street Group LLC ($1.20M), and Adage Capital Partners GP L.L.C. ($1.03M).

Institutional investors have bought a total of 23,711,050 shares in the last 24 months. This purchase volume represents approximately $48.67M in transactions.

Of the 14 institutional investors that sold C4 Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Orbimed Advisors LLC ($5.97M), Wasatch Advisors LP ($4.46M), Adage Capital Partners GP L.L.C. ($1.35M), Millennium Management LLC ($835.26K), Dimensional Fund Advisors LP ($135.41K), BNP Paribas Financial Markets ($125.37K), and OMERS ADMINISTRATION Corp ($58K).

Institutional investors have sold a total of 13,104,103 shares in the last 24 months. This volume of shares sold represents approximately $27.19M in transactions.



Institutional ownership data for NASDAQ:CCCC is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/6/2026. New 13F filings are added each quarter as they're published.
From Our Partners